The pharmaceutical industry is witnessing growing demand for anti-malarial and immunomodulatory therapies, supporting the expansion of the chloroquine market globally. Rising healthcare investments, increasing prevalence of infectious diseases, and the need for affordable treatment solutions are contributing to market growth. Chloroquine market is expected to register a CAGR of 8.09% from 2026...

API Intermediates Market Overview The Global API Intermediates Market is expanding at a strong pace as pharmaceutical companies worldwide increase production of active pharmaceutical ingredients (APIs) to meet rising demand for generics, biologics, and specialty medications. The market size was valued at USD 2.68 billion in 2024 and is expected to reach USD...

API Intermediates Market Overview The Global API Intermediates Market is expanding at a strong pace as pharmaceutical companies worldwide increase production of active pharmaceutical ingredients (APIs) to meet rising demand for generics, biologics, and specialty medications. The market size was valued at USD 2.68 billion in 2024 and is expected to reach USD...

Below is a structured market-insight framework for the Personalized Immunotherapy for Autoimmune Diseases Market, including real company references with numerical values, collaborations, or technology examples. Personalized Immunotherapy for Autoimmune Diseases Market 1. Recent Developments Eli Lilly and Company + Repertoire Immune Medicines In 2026, Eli Lilly...